February 2019
Commercial Medical Drug Prior Authorization Program adds Hemlibra
Beginning March 1, 2019, Hemlibra® will be added to the Medical Drug Prior Authorization Program for Blue Cross Blue Shield of Michigan commercial PPO members. This change applies to members starting therapy on or after March 1.
Drug name |
HCPCS code |
Hemlibra® (emicizumab-kxwh) |
J7170 |
Click here to see a list of all medications that require medical drug prior authorization as of March 1, 2019. Keep in mind that prior authorization provides clinical review approval only; it’s not a guarantee of payment.
You can request medical drug prior authorization by using one of the following methods:
Electronic: |
Provider Secured Services — NovoLogix tool |
Fax: |
1-877-325-5979 |
Phone: |
1-800-437-3803 |
Mail: |
BCBSM Specialty Pharmacy Program
P.O. Box 312320
Detroit, MI 48231-2320 |
You can find prior authorization forms for physician-administered medications on web-DENIS. When logged in, follow these steps:
- Click on BCBSM Provider Publications and Resources.
- Click on Commercial Pharmacy Prior Authorization and Step Therapy forms.
- Under Other Resources,click on Forms.
- Click on Physician administered medications.
Refer to the opt-out list for Blue Cross PPO groups that don’t require members to participate in the Commercial Medical Drug Prior Authorization Program. To access the list, follow these steps:
- When logged in to web-DENIS, click on BCBSM Provider Publications and Resources.
- Click on Newsletters & Resources.
- Click on Forms.
- Click on Physician administered medications.
- Click on BCBSM Medical Drug Prior Authorization Program list of groups that have opted out.
Note: The prior authorization requirement doesn’t apply to Blue Cross Medicare Plus BlueSM PPO or Federal Employee Program® members.
Blue Cross reserves the right to make changes to the medical drug prior authorization list at any time.
|